UPDATE ON FILING OF QUARTERLY REPORTS ON FORM 10-Q FOR THE QUARTERS ENDED JUNE 30, 2022 AND SEPTEMBER 30 2022
February 21, 2023 07:30 ET
|
Vinco Ventures, Inc.
Syracuse, NY, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vinco Ventures, Inc. (Nasdaq: BBIG) (“Vinco Ventures,” “Vinco,” or the “Company”), a digital media and content technologies company, announces that it...
PCS Edventures! Reports Unaudited Results for the Second Quarter of Fiscal Year 2023
February 09, 2023 07:00 ET
|
PCS Edventures!, Inc.
BOISE, Idaho, Feb. 09, 2023 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone...
Celyad Oncology provides fourth quarter 2022 business update and 2023 outlook
February 03, 2023 01:00 ET
|
Celyad Oncology SA
Celyad Oncology has implemented a strategic shift from an organization focused on clinical development to one fully harnessing the true potential of its proprietary technology platforms and...
U.S. Offshore Wind Sees Strong Fourth Quarter, But Challenges Loom Large in 2023
January 12, 2023 10:06 ET
|
Business Network for Offshore Wind
Baltimore, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The American offshore wind industry closed 2022 strong despite impending challenges and economic uncertainty, according to the U.S. Offshore Wind...
Immatics veröffentlicht Ergebnisse des dritten Quartals 2022 sowie ein Update zur Geschäftsentwicklung
November 17, 2022 07:00 ET
|
Immatics N.V.
Klinisches Daten-Update zu ACTengine® IMA203 TCR-T-Monotherapie gegen die Zielstruktur PRAME zeigt hohe bestätigte objektive Ansprechrate (confirmed objective response rate, cORR) von 50 % (6/12) bei...
Immatics Announces Third Quarter 2022 Financial Results and Business Update
November 17, 2022 07:00 ET
|
https://immatics.com/
Interim clinical update on ACTengine® IMA203 TCR-T monotherapy targeting PRAME demonstrated high confirmed objective response rate (cORR) of 50% (6/12) at or above target dose across Phase 1a and...
Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights
November 10, 2022 01:01 ET
|
Celyad Oncology SA
Company continues to transition business focus to monetizing unique cell therapy intellectual property and prioritizing R&D discoveryClinical updates expected by end of year for the Phase 1...
Lavras Gold’s Third Quarter Marked by Discovery
November 07, 2022 16:45 ET
|
Lavras Gold Corp
The news release should be read in conjunction with our unaudited interim consolidated financial statements and management’s discussion and analysis for the period ended September 30, 2022. Both are...
Ashton Woods USA L.L.C. Announces Quarterly Results Conference Call
September 30, 2022 09:00 ET
|
Ashton Woods Homes
Alpharetta, Ga., Sept. 30, 2022 (GLOBE NEWSWIRE) -- ASHTON WOODS USA L.L.C. ANNOUNCES QUARTERLY RESULTS CONFERENCE CALL Ashton Woods USA L.L.C. (the “Company”) announced today that the...
Connexa Sports Technologies Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
September 26, 2022 08:00 ET
|
Connexa Sports Technologies Inc.
Baltimore, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (NASDAQ: CNXA) (www.connexasports.com) (the “Company”) announced that it had received a letter from The Nasdaq Stock...